GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Carasent AB (publ) (STU:E0C) » Definitions » Cash Ratio

Carasent AB (publ) (STU:E0C) Cash Ratio : 2.22 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Carasent AB (publ) Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Carasent AB (publ)'s Cash Ratio for the quarter that ended in Mar. 2025 was 2.22.

Carasent AB (publ) has a Cash Ratio of 2.22. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Carasent AB (publ)'s Cash Ratio or its related term are showing as below:

STU:E0C' s Cash Ratio Range Over the Past 10 Years
Min: 0.47   Med: 4.73   Max: 120.97
Current: 2.25

During the past 13 years, Carasent AB (publ)'s highest Cash Ratio was 120.97. The lowest was 0.47. And the median was 4.73.

STU:E0C's Cash Ratio is ranked better than
83.23% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 0.58 vs STU:E0C: 2.25

Carasent AB (publ) Cash Ratio Historical Data

The historical data trend for Carasent AB (publ)'s Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carasent AB (publ) Cash Ratio Chart

Carasent AB (publ) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.35 8.10 7.41 3.90 2.23

Carasent AB (publ) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.24 3.37 3.48 2.23 2.22

Competitive Comparison of Carasent AB (publ)'s Cash Ratio

For the Health Information Services subindustry, Carasent AB (publ)'s Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carasent AB (publ)'s Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Carasent AB (publ)'s Cash Ratio distribution charts can be found below:

* The bar in red indicates where Carasent AB (publ)'s Cash Ratio falls into.


;
;

Carasent AB (publ) Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Carasent AB (publ)'s Cash Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash Ratio (A: Dec. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=22.779/10.204
=2.23

Carasent AB (publ)'s Cash Ratio for the quarter that ended in Mar. 2025 is calculated as:

Cash Ratio (Q: Mar. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=23.115/10.393
=2.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carasent AB (publ)  (STU:E0C) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Carasent AB (publ) Cash Ratio Related Terms

Thank you for viewing the detailed overview of Carasent AB (publ)'s Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Carasent AB (publ) Business Description

Traded in Other Exchanges
Address
Ovre Slottsgate 2B, Oslo, NOR, 0157
Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.

Carasent AB (publ) Headlines

No Headlines